WEST PHARMACEUTICAL SERVICES (1WST.MI) Fundamental Analysis & Valuation

BIT:1WST • US9553061055

Current stock price

214 EUR
+214 (+Infinity%)
Last:

This 1WST.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. 1WST.MI Profitability Analysis

1.1 Basic Checks

  • 1WST had positive earnings in the past year.
  • 1WST had a positive operating cash flow in the past year.
  • In the past 5 years 1WST has always been profitable.
  • Each year in the past 5 years 1WST had a positive operating cash flow.
1WST.MI Yearly Net Income VS EBIT VS OCF VS FCF1WST.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 11.56%, 1WST belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
  • 1WST's Return On Equity of 15.54% is fine compared to the rest of the industry. 1WST outperforms 77.27% of its industry peers.
  • 1WST has a better Return On Invested Capital (14.09%) than 90.91% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for 1WST is significantly above the industry average of 9.09%.
Industry RankSector Rank
ROA 11.56%
ROE 15.54%
ROIC 14.09%
ROA(3y)13.53%
ROA(5y)15.35%
ROE(3y)18.17%
ROE(5y)20.93%
ROIC(3y)15.83%
ROIC(5y)17.92%
1WST.MI Yearly ROA, ROE, ROIC1WST.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • 1WST's Profit Margin of 16.06% is fine compared to the rest of the industry. 1WST outperforms 72.73% of its industry peers.
  • In the last couple of years the Profit Margin of 1WST has remained more or less at the same level.
  • 1WST has a better Operating Margin (20.53%) than 81.82% of its industry peers.
  • In the last couple of years the Operating Margin of 1WST has remained more or less at the same level.
  • 1WST has a Gross Margin (35.91%) which is in line with its industry peers.
  • 1WST's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.53%
PM (TTM) 16.06%
GM 35.91%
OM growth 3Y-7.75%
OM growth 5Y1.08%
PM growth 3Y-7.51%
PM growth 5Y-0.08%
GM growth 3Y-3.01%
GM growth 5Y0.08%
1WST.MI Yearly Profit, Operating, Gross Margins1WST.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. 1WST.MI Health Analysis

2.1 Basic Checks

  • 1WST has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 1WST has less shares outstanding
  • 1WST has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, 1WST has an improved debt to assets ratio.
1WST.MI Yearly Shares Outstanding1WST.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
1WST.MI Yearly Total Debt VS Total Assets1WST.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 12.77 indicates that 1WST is not in any danger for bankruptcy at the moment.
  • 1WST has a better Altman-Z score (12.77) than 100.00% of its industry peers.
  • 1WST has a debt to FCF ratio of 0.44. This is a very positive value and a sign of high solvency as it would only need 0.44 years to pay back of all of its debts.
  • 1WST has a better Debt to FCF ratio (0.44) than 95.45% of its industry peers.
  • 1WST has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of 1WST (0.06) is better than 90.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.44
Altman-Z 12.77
ROIC/WACC1.29
WACC10.94%
1WST.MI Yearly LT Debt VS Equity VS FCF1WST.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 3.02 indicates that 1WST has no problem at all paying its short term obligations.
  • The Current ratio of 1WST (3.02) is better than 86.36% of its industry peers.
  • 1WST has a Quick Ratio of 2.34. This indicates that 1WST is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of 1WST (2.34) is better than 86.36% of its industry peers.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 2.34
1WST.MI Yearly Current Assets VS Current Liabilites1WST.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1WST.MI Growth Analysis

3.1 Past

  • 1WST shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 8.00%.
  • The Earnings Per Share has been growing by 8.94% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 6.25% in the past year.
  • 1WST shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.44% yearly.
EPS 1Y (TTM)8%
EPS 3Y-5.25%
EPS 5Y8.94%
EPS Q2Q%12.09%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y2.12%
Revenue growth 5Y7.44%
Sales Q2Q%7.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 9.50% on average over the next years. This is quite good.
  • 1WST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.60% yearly.
EPS Next Y11.14%
EPS Next 2Y11.07%
EPS Next 3Y11.63%
EPS Next 5Y9.5%
Revenue Next Year6.01%
Revenue Next 2Y6.04%
Revenue Next 3Y6.31%
Revenue Next 5Y5.6%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
1WST.MI Yearly Revenue VS Estimates1WST.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
1WST.MI Yearly EPS VS Estimates1WST.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1WST.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 33.91, 1WST can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of 1WST indicates a slightly more expensive valuation: 1WST is more expensive than 63.64% of the companies listed in the same industry.
  • 1WST is valuated rather expensively when we compare the Price/Earnings ratio to 25.60, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 30.50 indicates a quite expensive valuation of 1WST.
  • 63.64% of the companies in the same industry are cheaper than 1WST, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of 1WST to the average of the S&P500 Index (22.84), we can say 1WST is valued slightly more expensively.
Industry RankSector Rank
PE 33.91
Fwd PE 30.5
1WST.MI Price Earnings VS Forward Price Earnings1WST.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1WST is valued a bit more expensive than 68.18% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1WST.
Industry RankSector Rank
P/FCF 37.95
EV/EBITDA 21.45
1WST.MI Per share data1WST.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1WST does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of 1WST may justify a higher PE ratio.
PEG (NY)3.04
PEG (5Y)3.79
EPS Next 2Y11.07%
EPS Next 3Y11.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. 1WST.MI Dividend Analysis

5.1 Amount

  • 1WST has a yearly dividend return of 0.32%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.52, 1WST has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.90, 1WST's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

  • The dividend of 1WST has a limited annual growth rate of 5.48%.
Dividend Growth(5Y)5.48%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • 12.40% of the earnings are spent on dividend by 1WST. This is a low number and sustainable payout ratio.
  • The dividend of 1WST is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12.4%
EPS Next 2Y11.07%
EPS Next 3Y11.63%
1WST.MI Yearly Income VS Free CF VS Dividend1WST.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
1WST.MI Dividend Payout.1WST.MI Dividend Payout, showing the Payout Ratio.1WST.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

1WST.MI Fundamentals: All Metrics, Ratios and Statistics

WEST PHARMACEUTICAL SERVICES

BIT:1WST (3/3/2026, 7:00:00 PM)

214

+214 (+Infinity%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-12
Earnings (Next)04-22
Inst Owners97.62%
Inst Owner ChangeN/A
Ins Owners0.33%
Ins Owner ChangeN/A
Market Cap15.41B
Revenue(TTM)3.07B
Net Income(TTM)493.70M
Analysts80.87
Price Target283.43 (32.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.74
Dividend Growth(5Y)5.48%
DP12.4%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.82%
Min EPS beat(2)10.24%
Max EPS beat(2)15.4%
EPS beat(4)4
Avg EPS beat(4)15.68%
Min EPS beat(4)10.24%
Max EPS beat(4)20.68%
EPS beat(8)7
Avg EPS beat(8)12.16%
EPS beat(12)11
Avg EPS beat(12)11.7%
EPS beat(16)14
Avg EPS beat(16)11.27%
Revenue beat(2)2
Avg Revenue beat(2)0.72%
Min Revenue beat(2)0.33%
Max Revenue beat(2)1.1%
Revenue beat(4)4
Avg Revenue beat(4)1.63%
Min Revenue beat(4)0.33%
Max Revenue beat(4)4.33%
Revenue beat(8)7
Avg Revenue beat(8)1.11%
Revenue beat(12)8
Avg Revenue beat(12)0.49%
Revenue beat(16)10
Avg Revenue beat(16)0.34%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.91
Fwd PE 30.5
P/S 5.79
P/FCF 37.95
P/OCF 23.58
P/B 5.6
P/tB 5.82
EV/EBITDA 21.45
EPS(TTM)6.31
EY2.95%
EPS(NY)7.02
Fwd EY3.28%
FCF(TTM)5.64
FCFY2.63%
OCF(TTM)9.08
OCFY4.24%
SpS36.97
BVpS38.19
TBVpS36.78
PEG (NY)3.04
PEG (5Y)3.79
Graham Number73.64
Profitability
Industry RankSector Rank
ROA 11.56%
ROE 15.54%
ROCE 17.45%
ROIC 14.09%
ROICexc 18.03%
ROICexgc 18.82%
OM 20.53%
PM (TTM) 16.06%
GM 35.91%
FCFM 15.25%
ROA(3y)13.53%
ROA(5y)15.35%
ROE(3y)18.17%
ROE(5y)20.93%
ROIC(3y)15.83%
ROIC(5y)17.92%
ROICexc(3y)20.32%
ROICexc(5y)23.97%
ROICexgc(3y)21.34%
ROICexgc(5y)25.37%
ROCE(3y)19.61%
ROCE(5y)22.21%
ROICexgc growth 3Y-13.74%
ROICexgc growth 5Y-3.06%
ROICexc growth 3Y-13.28%
ROICexc growth 5Y-2.17%
OM growth 3Y-7.75%
OM growth 5Y1.08%
PM growth 3Y-7.51%
PM growth 5Y-0.08%
GM growth 3Y-3.01%
GM growth 5Y0.08%
F-Score7
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.44
Debt/EBITDA 0.26
Cap/Depr 166.8%
Cap/Sales 9.3%
Interest Coverage 2103.33
Cash Conversion 94.07%
Profit Quality 94.98%
Current Ratio 3.02
Quick Ratio 2.34
Altman-Z 12.77
F-Score7
WACC10.94%
ROIC/WACC1.29
Cap/Depr(3y)224.35%
Cap/Depr(5y)223.25%
Cap/Sales(3y)11.53%
Cap/Sales(5y)10.68%
Profit Quality(3y)73.64%
Profit Quality(5y)69.18%
High Growth Momentum
Growth
EPS 1Y (TTM)8%
EPS 3Y-5.25%
EPS 5Y8.94%
EPS Q2Q%12.09%
EPS Next Y11.14%
EPS Next 2Y11.07%
EPS Next 3Y11.63%
EPS Next 5Y9.5%
Revenue 1Y (TTM)6.25%
Revenue growth 3Y2.12%
Revenue growth 5Y7.44%
Sales Q2Q%7.51%
Revenue Next Year6.01%
Revenue Next 2Y6.04%
Revenue Next 3Y6.31%
Revenue Next 5Y5.6%
EBIT growth 1Y7.88%
EBIT growth 3Y-5.8%
EBIT growth 5Y8.6%
EBIT Next Year43.23%
EBIT Next 3Y19.91%
EBIT Next 5Y13.54%
FCF growth 1Y69.65%
FCF growth 3Y2.19%
FCF growth 5Y9.48%
OCF growth 1Y15.52%
OCF growth 3Y1.4%
OCF growth 5Y9.82%

WEST PHARMACEUTICAL SERVICES / 1WST.MI Fundamental Analysis FAQ

What is the fundamental rating for 1WST stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1WST.MI.


What is the valuation status for 1WST stock?

ChartMill assigns a valuation rating of 1 / 10 to WEST PHARMACEUTICAL SERVICES (1WST.MI). This can be considered as Overvalued.


What is the profitability of 1WST stock?

WEST PHARMACEUTICAL SERVICES (1WST.MI) has a profitability rating of 7 / 10.


Can you provide the financial health for 1WST stock?

The financial health rating of WEST PHARMACEUTICAL SERVICES (1WST.MI) is 10 / 10.


Can you provide the dividend sustainability for 1WST stock?

The dividend rating of WEST PHARMACEUTICAL SERVICES (1WST.MI) is 4 / 10 and the dividend payout ratio is 12.4%.